Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07538180
What this trial is testing

Serplulimab, Chidamide, and Rituximab Followed by Sequential R-CHOP for Newly Diagnosed Elderly MYC/BCL2 Double-Expressor DLBCL

Who this might be right for
Newly Diagnosed MYC/BCL2 Double-expressor DLBCL
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT02955823
What this trial is testing

A Phase II Study of the FIL on Elderly Frail Patients With DLBCL

Who this might be right for
Diffuse Large B-cells Non-Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 68
Testing effectiveness (Phase 2)Study completedNCT01149850
What this trial is testing

Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Giant Cell GlioblastomaGlioblastomaGliosarcoma
Jonsson Comprehensive Cancer Center 50
Not applicableLooking for participantsNCT06923618
What this trial is testing

Cancer of the Lung And SeneScencE - Prospective Cohort 1

Who this might be right for
Non-Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 385
Not applicableLooking for participantsNCT07420790
What this trial is testing

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

Who this might be right for
Acute Myeloid Leukemia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941
Not applicableNot Yet RecruitingNCT07703774
What this trial is testing

Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60

Who this might be right for
Myeloid Cell Infiltration
University of Taipei 60
Not applicableStudy completedNCT02755584
What this trial is testing

Study of Skin Cells That Stop Replicating (Senescent) During Wound Healing

Who this might be right for
Healthy Volunteers
National Institute on Aging (NIA) 75
Testing effectiveness (Phase 2)UnknownNCT04748471
What this trial is testing

Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)

Who this might be right for
Prevention of COVID19
Assistance Publique - Hôpitaux de Paris 180
Testing effectiveness (Phase 2)Study completedNCT00717834
What this trial is testing

Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine

Who this might be right for
Ross River Virus Disease (RRVD)
Alachua Government Services, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT01686321
What this trial is testing

Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma

Who this might be right for
Aggressive Lymphoma
University of Göttingen 68
Large-scale testing (Phase 3)Looking for participantsNCT06830421
What this trial is testing

Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Who this might be right for
Primary Central Nervous System Lymphoma
University Hospital Freiburg 340
Not applicableEnded earlyNCT06503458
What this trial is testing

A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia
Sanguine Biosciences 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT05911321
What this trial is testing

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

Who this might be right for
Multiple MyelomaRelapseRefractory+2 more
UNC Lineberger Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT06851832
What this trial is testing

Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older

Who this might be right for
Herpes ZosterHerpes Zoster Vaccine
Ab&B Bio-tech Co., Ltd.JS 960
Testing effectiveness (Phase 2)Looking for participantsNCT06032052
What this trial is testing

Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

Who this might be right for
Elderly PatientsMetastatic Lung Cancer
Hubei Cancer Hospital 49
Testing effectiveness (Phase 2)Study completedNCT00401609
What this trial is testing

G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients

Who this might be right for
Small Cell Lung Cancer
National Cancer Institute, Naples 85
Testing effectiveness (Phase 2)Study completedNCT04884685
What this trial is testing

Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 500
Testing effectiveness (Phase 2)Study completedNCT05323435
What this trial is testing

Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV)

Who this might be right for
COVID-19
Jiangsu Rec-Biotechnology Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT06754384
What this trial is testing

Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Who this might be right for
Hand, Foot, and Mouth Disease (HFMD)Herpangina
Sinovac Biotech Co., Ltd 552
Not applicableLooking for participantsNCT04300998
What this trial is testing

Study of CAR-T Therapy in Older Patients

Who this might be right for
LymphomaRefractory B-Cell LymphomaLymphoma, B-Cell+3 more
Memorial Sloan Kettering Cancer Center 154
Next Page